M orphea (localized scleroderma) is characterized by thickening of the skin resulting from inflammation and the deposition of collagen-rich extracellular matrix. Although the demographic and clinical features of morphea have been the focus of many recent publications, the histologic features remain poorly described.
Histopathological features of morphea may be a readily accessible aid in evaluating patients with morphea in addition to establishing the diagnosis. Existing studies are limited by reliance on very few specimens (in some cases 1-2 patients) with relatively scant clinical information, making clinicopathologic correlation difficult. [1] [2] [3] [4] Although the validation of new outcome measures in morphea are valuable, skin biopsy may provide additional information regarding depth of involvement and activity (inflammation) in cases where clinical examination is inconclusive and ultrasound or magnetic resonance imaging are not readily available. [5] [6] [7] [8] Studies that systematically describe the histologic features of morphea in a wellcharacterized cohort of patients are needed to provide correlation between clinical and histologic findings. This would allow practitioners to use histologic in addition to clinical findings as an aid in decision making. [9] [10] [11] This study, referred to as the Morphea in Adults and Children (MAC) cohort, was designed to examine demographic, clinical, and histologic features in a thoroughly phenotyped cohort of participants with morphea. By studying patients in a prospective cross-sectional manner, we aimed to define the histologic attributes of morphea and determine their association with clinical features.
METHODS

Patients and procedures
The institutional review boardeapproved MAC cohort contained 229 adults and children ($18 years and 3-17 years old at enrollment, respectively) at the time of this study (details previously published). 12 After consent, all data were abstracted using a case report form and medical records were reviewed.
Inclusion criteria were: enrollment in the MAC cohort, skin biopsy performed at enrollment or within 3 months of enrollment, and determination of relevant clinical variables within 3 months of the biopsy (with no intervening treatment). All patients were examined by a single physician with expertise in morphea (H. J.) who assigned subtype and clinical scores. Clinical subtypes included circumscribed, linear, generalized, profunda, and morphea with lichen sclerosus features (as previously defined). 13, 14 Two generalized morphea subgroups were assigned including isomorphic (eg, lesions occurring in areas of friction: waistline; more common in older, postmenopausal women) 15 and symmetric morphea (lesions arranged symmetrically about the anatomical midline).
At the time of enrollment, 4.0-mm punch biopsies were performed at the erythematous border in inflammatory lesions, or central sclerosis of lesions without clinical inflammation (Fig 1) . 7 If biopsies were performed off site by the referring provider, these slides were obtained and examined in the same manner as specimens obtained by the principal investigator. In addition, patients with biopsies done before enrollment were included only if their biopsy site was clearly identifiable by examination. Photographs were taken to note the site of biopsy (Fig 1) for all enrolled patients. All specimens were fixed in formalin and stained with hematoxylin and eosin.
Clinical variables
The MAC database contains the following domains: demographic, clinical, physician-based determinants of disease severity (modified Rodnan Skin Score, functional status) and patient-based assessment of diseaserelated symptoms as represented on a 10-point visual analog scale. At the inception of the cohort there were no validated clinical outcome measures for morphea. Although not validated in morphea, the modified Rodnan Skin Score was selected as a measure of clinical severity because of its validation in systemic sclerosis and its use in published morphea studies at the time. 16 The newly validated Localized Scleroderma Cutaneous Assessment Tool was administered to patients after 2010. 7 Too few patients had Localized Scleroderma Cutaneous Assessment Tool scores for meaningful analysis in this study.
Histopathological examination
All specimens were examined at Cockrell Dermatopathology Laboratories (Dallas, TX) by the same blinded, board-certified dermatopathologist (J. S. S.). In all, 25 slides were randomly selected for blinded examination by a second board-certified dermatopathologist using the same protocol as the primary dermatopathologist.
Histology was examined with a microscope (BX45, Olympus) and observations were recorded for the severity and microanatomical location of sclerosis and inflammation. Assessment of severity
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of sclerosis included a previously published global sclerosis score assessing extent of histologic sclerosis (severe, moderate, or mild). 10 The pattern of sclerosis was determined based on the microanatomical location of hyalinized collagen. A top-heavy pattern (Fig 2, A) was defined by hyalinized collagen bundles exclusively in the papillary to superficial reticular dermis with an absence of these changes below. A bottom-heavy pattern was defined by hyalinized collagen bundles present in the reticular dermis and subcutis and sparing of the papillary through mid dermis (Fig 2, B) , and a fullthickness pattern had thickened collagen bundles throughout the dermis. The degree of inflammation was graded as mild (mild perivascular infiltrate), moderate (dense perivascular infiltrate), or severe (dense infiltrate of inflammatory cells that may be located in a perivascular, periadnexal, and/or interstitial location or at the dermal and subcutaneous junction in which the density of the inflammatory cell infiltrate is such that it takes on the appearance of a round ''nodule'' of inflammatory cells). Additional assessment included documenting cell types present (plasma cells, lymphocytes, and eosinophils), considered ''present'' if greater than 5 were seen at low power. Location of the inflammatory infiltrate was determined by: perivascular ([10 cells aggregated around capillaries), periadnexal ([10 cells aggregated around adnexal structures), interstitial, dermal subcuticular junction, septal, or lobular.
Statistical analysis
Data were tabulated using descriptive statistics, frequency tables, and frequency distributions. Fisher exact test was used to test the association between morphea subtype and clinical characteristics with global sclerosis score, pattern of sclerosis (top heavy, bottom heavy, throughout), degree of inflammation (mild, moderate, severe), and cell type. A kappa score was calculated to assess agreement between dermatopathologists. Values greater than 0.6 were considered acceptable. A P value less than .05 was assigned for statistical significance for all analyses. Statistical analysis software (GraphPad Prism, Version 5.04, GraphPad Software, La Jolla, CA) was used.
RESULTS
Of the 229 patients in the cohort, 83 met enrollment criteria. Excluded patients were children who were not biopsied as part of enrollment (the children in the current study were biopsied by their referring dermatologist, n = 9) or adults who declined biopsy at enrollment (n = 137). Those who declined were similar in age, race, and gender as those who were biopsied. In addition, cosmetically sensitive sites (the face) and those prone to poor wound healing (anterior tibia and the like) were not biopsied for patient safety (N = 12). In all, 91 skin biopsy specimens were obtained from 83 patients. Of the 91 biopsy specimens taken, 71 included the subcutis. The demographic and clinical features of the 83 patients in this study are available in Table I .
Histologic features
Microanatomical location of sclerosis. Microanatomical locations are in Table II . Of specimens, 31 of 91 (34%) had a top-heavy sclerosis pattern, 22 of 91 (24%) had full-thickness sclerosis, and 39 of 91 (43%) had a bottom-heavy pattern. Microanatomical location of sclerosis was analyzed relative to clinical subtype. Specimens from patients with morphea profunda (defined as involvement of the subcutis or deeper on direct pathological examination or magnetic resonance imaging/ultrasound imaging of the affected area) had bottom-heavy or full-thickness patterns of sclerosis in the dermis (13/13, P = .012). A bottom-heavy or full-thickness sclerosis pattern also predominated in specimens from symmetric generalized morphea (10/12, P = .025). A top-heavy sclerosis pattern was more common in patients who had clinical features of lichen sclerosus accompanying morphea (6/7, P = .0058). Specimens from linear and plaque morphea specimens exhibited all 3 patterns of sclerosis with similar frequency (there was no statistical difference in the frequency of different patterns of sclerosis).
Inflammatory cell infiltrate. Details of inflammatory cell infiltrate are available in Table III . The majority of specimens had mild (43/91, 47%), to moderate (31/91, 34%) inflammation. Degree of inflammation was equally distributed among all J AM ACAD DERMATOL subtypes (no statistically significant difference in frequency). When inflammation was present, lymphocytes were the predominant cell type (83/91, 91%). Plasma cells were the second most common cell type present (68/91, 75%). Nineteen of 91 (21%) specimens had eosinophils. Inflammatory cells were present in the papillary (89/91, 97%) and deep perivascular (82/91, 90%) dermis. The dermalsubcutaneous interface (58/91, 64%) and periadnexal areas (59/91, 65%) were also highly enriched with inflammatory cell infiltrate. Inflammatory cells were often found along the dermal-subcutaneous interface when bottom-heavy and full-thickness sclerosis was present (41/61, 67.2%). Sclerosis and inflammation (defined as presence of mild, moderate, to severe inflammation, and any sclerosis [top/bottom heavy or full thickness]) occurred simultaneously in 46.2% (42/91). Table IV summarizes the results of clinicopathologic association analyses for pattern of sclerosis.
Clinicopathologic association
Clinicopathologic association: Pattern of sclerosis. Patient-perceived pain and tightness were more common in specimens with bottomheavy sclerosis (23/37, 62%, P = .0039, and 20/36, 56%, P = .001, respectively). Patients with specimens with a top-heavy sclerosis pattern reported pain and tightness in their lesions less frequently than those with a bottom-heavy pattern of sclerosis (6/24, 25%, P = .05, and 4/24, 17%, P = .04. respectively).
Clinicopathologic association: Degree of inflammation. Of the specimens with severe inflammation on biopsy, there was a trend toward increased presence of pain and functional limitation versus those with little or no inflammation (6/8, 75%, P = .073 had pain and 5/8, 63%, P = .073 had functional impairment).
Clinicopathologic association: Global sclerosis score. There were no significant associations between global sclerosis scores and any clinical variables. Functional limitation and deep involvement were more frequent in grade 3 sclerosis but failed to reach significance.
Measures of agreement
Interobserver correlation studies of global sclerosis scores yielded an interuser agreement ratio of 87.5%, kappa = 0.755; degree of inflammation interuser agreement ratio = 80.0%, k = 0.706; and sclerosis pattern interuser agreement ratio = 75%, k = 0.602.
DISCUSSION
To date, few studies have systematically examined the histopathological findings in morphea using predetermined clinical and histologic criteria. Fig 2. A, Top-heavy morphea. Sclerosis is moderate to severe in the papillary and superficial reticular dermis, whereas the mid and reticular dermis is relatively spared. B, Bottom-heavy morphea. Sclerosis is moderate to severe in the mid and reticular dermis, whereas the superficial and papillary dermis is relatively spared. This cross-sectional study was designed to address this deficit. We found that specific histologic characteristics were associated with morphea subtype and patient-reported symptoms. Results of this study are similar to prior reports describing the presence of sclerosis at any level of the dermis including the superficial papillary dermis extending into the panniculus producing septal sclerosis in morphea. [1] [2] [3] We confirmed the findings of McNiff et al 4 that morphea may be limited to the superficial reticular dermis. In fact, this occurred in 34% of our specimens, which we termed a ''topheavy'' sclerosis pattern. New to this study, we found that all patterns of sclerosis occur with nearly equal frequency in morphea overall indicating that the term ''morphea profunda'' may not be indicative of a distinct morphea subtype, but rather reflect a finding that may occur in linear, plaque, and generalized subtypes.
We also examined the relationship between the pattern of sclerosis and morphea subtypes and symptoms. The 3 microanatomical locations of sclerosis (top heavy, bottom heavy, and throughout) were present in all morphea subtypes, but in different frequencies. In the case of linear and circumscribed subtypes, all 3 patterns were present with equal frequency. Not unexpectedly, morphea profunda predominated with deep or throughout patterns whereas patients with lichen sclerosus overlap displayed top-heavy sclerosis. We found 2 patterns of sclerosis dominated in patients who met criteria for generalized morphea. In 1 subset, generalized symmetric morphea, bottom-heavy sclerosis predominated. In patients with isomorphic morphea (which our group described previously) top-heavy patterns of sclerosis predominated. 15 Isomorphic lesions occur in sites of chronic friction (waistband area). The superficial distribution of histologic changes in isomorphic morphea further supports chronic superficial trauma in the pathogenesis of these lesions. Moreover, the presence of a bottom-heavy, or deeper, pattern of sclerosis was associated with the presence of symptoms such as pain, tightness, and functional impairment in patients with all subtypes, whereas patients with top-heavy sclerosis patterns had less frequent pain, tightness, and functional impairment. Prior reports indicate perineural inflammation is present in morphea. 2, 3 The presence of deep sclerosis, in some cases perineurally, may account for the presence of pain. Taken together, these results indicate that the pattern of sclerosis, not clinical subtype alone, may predict the clinical severity of morphea. This may account for the clinical heterogeneity of morphea, which ranges from mild cosmetic impairment to extreme pain and disability even within the same subtype. [17] [18] [19] This supports the use of the pattern of sclerosis as a clinical indicator in Top heavy is defined as hyalinized collagen bundles exclusively in the papillary/reticular dermis. Bottom heavy is defined as sparing of papillary to mid dermis with hyalinized collagen bundles present in the reticular dermis and subcutis. Full thickness is defined as hyalinized collagen bundles throughout the dermis and extending into subcutis. Numbers are presented as frequency and percent in parentheses. *Significant associations between sclerosis pattern and subtype. Numbers are presented as frequency and percent in parentheses. There were no statistically significant associations among degree of inflammation, cell type, and morphea subtype.
addition to subtype and distribution of lesions in evaluation.
We also examined the characteristics of the inflammatory cell infiltrate in morphea. Our results confirm those of Torres and Sanchez 1 and Fleischmajer and Nedwich, 2 in which 84% of 43 patients with morphea had lymphoplasmacytic infiltrates present both in the dermis and subcutis. We found lymphocytes in 91.2% of our specimens and plasma cells in 74.7% of specimens. The presence of plasma cells in addition to lymphocytes in 75% of specimens is congruent with current theories of the mechanism of fibrosis implicating a T helper cell 2-dominated immune response. 20, 21 Skewed activation of the adaptive immune response producing a T helper cell 2-dominant pattern of cytokine release is thought to be a key mediator of fibrosis and is associated with antibody production by plasma cells. Although prior studies 2 implicate a stepwise progression from inflammatory to sclerotic phases in morphea, inflammation and sclerosis were simultaneously present in this series. This implies that some patients with morphea have ongoing inflammation driving prolonged periods of sclerosis. 20, 21 Limitations of this study include low number of specimens especially when examining association between specific clinical and histologic features and lack of subcutaneous tissue in 20 of the specimens. Also, some biopsies were performed before clinical assessment by the morphea expert who evaluated each patient in the cohort. Every attempt was made to enhance the validity of these findings by only including patients who had biopsies done within 3 months of clinical assessment, who did not have intervening treatment, and where the biopsy site was identifiable and was taken from the inflammatory border of lesions. Lesion duration was not ascertained as it is prone to recall bias. In addition, disease duration has not been found to correlate with severity of individual lesions in patients with morphea. 19 Additional limitations include lack of biopsies from pediatric patients and those with lesions in cosmetically sensitive sites or areas prone to poor wound healing (as histologic features may differ in these sites). This also underscores that use of skin biopsy for evaluation may be limited in these clinical scenarios.
This study has several implications for practice. First, pathological findings, particularly pattern of sclerosis and degree of inflammation, have a role in patient evaluation and may function as an adjunct to subtype determination and sites of involvement for determining the probability of significant symptoms or functional impairment. Thus, biopsy in morphea may not just be indicated for diagnosis, but also assessment. Consequently, pathology reports should include descriptions of these findings. In turn, clinicians should be aware that the presence of a bottom-heavy pattern of sclerosis and severe inflammation may indicate the patient is at increased 
